[/(
Changes/NNS
in/IN
plasma/NN
interleukin-1/NN
and/CC
their/PRP$
possible/JJ
relationship/NN
with/IN
the/DT
changes/NNS
in/IN
glucocorticoid/NN
receptor/NN
in/IN
aged/JJ
long-distance/JJ
runner/NN
]/)

For/IN
the/DT
study/NN
of/IN
the/DT
changes/NNS
in/IN
plasma/NN
interleukin-1/NN
(/(
IL-1/NN
)/)
and/CC
their/PRP$
possible/JJ
relationship/NN
with/IN
the/DT
changes/NNS
in/IN
glucocorticoid/NN
receptor/NN
(/(
GR/NN
)/)
,/,
plasma/NN
IL-1/NN
and/CC
GR/NN
in/IN
peripheral/JJ
blood/NN
leukocytes/NNS
in/IN
aged/JJ
long-distance/JJ
runner/NN
were/VBD
measured/VBN
simultaneously/RB
./.
=====
The/DT
activity/NN
of/IN
IL-1/NN
was/VBD
expressed/VBN
as/IN
its/PRP$
ability/NN
to/TO
stimulate/VB
3H-TdR/NN
incorporation/NN
in/IN
the/DT
thymocytes/NNS
of/IN
C57/NN
mice/NNS
./.
=====
GR/NN
was/VBD
determined/VBN
by/IN
whole/JJ
cell/NN
assay/NN
with/IN
3H-Dex/NN
./.
=====
The/DT
results/NNS
showed/VBD
that/IN
the/DT
activity/NN
of/IN
plasma/NN
IL-1/NN
in/IN
aged/JJ
long-distance/JJ
runner/NN
was/VBD
209/CD
%/NN
,/,
223/CD
%/NN
and/CC
145/CD
%/NN
of/IN
the/DT
control/NN
at/IN
14.7-18.7/CD
,/,
3.8-7.0/CD
and/CC
1.5-2.6/CD
KD/NN
fractions/NNS
./.
=====
The/DT
GR/NN
in/IN
peripheral/JJ
blood/NN
leukocytes/NNS
in/IN
aged/JJ
runner/NN
was/VBD
65/CD
%/NN
of/IN
the/DT
control/NN
./.
=====
Possible/JJ
relationship/NN
between/IN
the/DT
changes/NNS
in/IN
IL-1/NN
and/CC
GR/NN
in/NN
aged/JJ
long-distance/JJ
runner/NN
and/CC
its/PRP$
physiological/JJ
significance/NN
are/VBP
discussed/VBN
./.